The TGR Board wish to advise that they have appointed Ms Anne Hinton as CEO of the company effective 1 February 2012. Anne, previously TGR’s CFO/COO, brings significant commercial experience having been with the company for 10 years, and prior to that held management consulting roles in her own business and for KPMG.
Ms Hinton will succeed Dr Leanna Read, who has resigned from the company from January 31, 2012 after leading the company for over 10 years. Leanna, the founding CEO of TGR, considers that it is timely to hand over the reins and move on to new challenges.
The Board would like to thank Leanna for her considerable efforts in leading the company to a position where it is held in high regard in the international biotechnology industry.